OLFML2A and central nervous system cancer: Similarly, gross observations also showed that OLFML2A downregulation could significantly suppress orthotopic glioma growth (Figure 9B), and the positive rate of Ki-67 was also decreased after OLFML2A knockdown (Figure 9C).